Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1446080
Abstract: ABSTRACT Introduction: Available data indicate that survivors of breast cancer and Hodgkin lymphoma who received mediastinal radiotherapy are at increased risk of developing radiation-induced cardiovascular diseases (RICVD) one or two decades after treatment. Although the… read more here.
Keywords: radiotherapy role; complications radiotherapy; cardiovascular complications; role new ... See more keywords
New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2019.1634543
Abstract: ABSTRACT Introduction: Genetic neuromuscular diseases (NMDs) constitute a heterogeneous group of rare conditions, including some of the most disabling conditions in childhood. Recently, advanced technologies have greatly expanded preclinical and clinical research, and specific therapies… read more here.
Keywords: neuromuscular disorders; pharmacotherapies genetic; opportunities challenges; disorders opportunities ... See more keywords